Ceftobiprole for Staphylococcus aureus Bacteremia REPLY
Publication
, Journal Article
Holland, TL; Engelhardt, M; Fowler, VGJ
Published in: NEW ENGLAND JOURNAL OF MEDICINE
December 28, 2023
Duke Scholars
Published In
NEW ENGLAND JOURNAL OF MEDICINE
EISSN
1533-4406
ISSN
0028-4793
Publication Date
December 28, 2023
Volume
389
Issue
26
Start / End Page
2499 / 2499
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Holland, T. L., Engelhardt, M., & Fowler, V. G. J. (2023). Ceftobiprole for Staphylococcus aureus Bacteremia REPLY. NEW ENGLAND JOURNAL OF MEDICINE, 389(26), 2499–2499.
Holland, Thomas L., Marc Engelhardt, and Vance G Jr Fowler. “Ceftobiprole for Staphylococcus aureus Bacteremia REPLY.” NEW ENGLAND JOURNAL OF MEDICINE 389, no. 26 (December 28, 2023): 2499–2499.
Holland TL, Engelhardt M, Fowler VGJ. Ceftobiprole for Staphylococcus aureus Bacteremia REPLY. NEW ENGLAND JOURNAL OF MEDICINE. 2023 Dec 28;389(26):2499–2499.
Holland, Thomas L., et al. “Ceftobiprole for Staphylococcus aureus Bacteremia REPLY.” NEW ENGLAND JOURNAL OF MEDICINE, vol. 389, no. 26, Dec. 2023, pp. 2499–2499.
Holland TL, Engelhardt M, Fowler VGJ. Ceftobiprole for Staphylococcus aureus Bacteremia REPLY. NEW ENGLAND JOURNAL OF MEDICINE. 2023 Dec 28;389(26):2499–2499.
Published In
NEW ENGLAND JOURNAL OF MEDICINE
EISSN
1533-4406
ISSN
0028-4793
Publication Date
December 28, 2023
Volume
389
Issue
26
Start / End Page
2499 / 2499
Related Subject Headings
- General & Internal Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences